Author

K. H. Byrd

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:mouse· 1 Assay:proteomics· 1 Approach:wet-lab / biochemical assay· 1

Frequent Co-Authors

C. Loo· 1 shared E. F. Lind· 1 shared H. J. Cho· 1 shared J. L. Coy· 1 shared J. Scott· 1 shared K. A. Romine· 1 shared M. T. Newman· 1 shared P. A. Flynn· 1 shared

Activity by Year

2021-2021 · peak 1/yr

Co-Author Collaboration Network

9 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

C. Loo

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

BET inhibitors synergize with anti-PD1 by rescuing TCF1+ progenitor exhausted CD8+ T cells in Acute Myeloid Leukemia

K. A. Romine, H. J. Cho, Y. Kosaka, K. H. Byrd, J. L. Coy, P. A. Flynn, M. T. Newman, C. Loo, J. Scott, E. F. Lind

This study shows BET inhibitors enhance anti-PD1 therapy by reversing T cell exhaustion in AML, increasing CD8+ T cell function and reducing leukemia cells.

bioRxiv · Aug 4, 2021 · PreprintCancer Biology